Results 271 to 280 of about 23,381 (306)
Some of the next articles are maybe not open access.
Treatment of Osteonecrosis of the Jaw
Journal of Craniofacial Surgery, 2015The definition of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was recently broadened and it is now known as medication-related osteonecrosis of the jaw (MRONJ). To date, the management of MRONJ is controversial. Conservative treatment is recommended, but it is difficult to successfully treat stage 3 MRONJ. Administration of teriparatide for
Eiki, Yamachika +5 more
openaire +2 more sources
Journal of the Korean Association of Oral and Maxillofacial Surgeons
Objectives This study aimed to compare composite radiographic index (CRI-index) findings of medication-related osteonecrosis of jaws (MRONJs) and non-medication related osteonecrosis of jaws (n-MRONJs) and predict factors predictive of recurrence and ...
Ilgın Arı +3 more
semanticscholar +1 more source
Objectives This study aimed to compare composite radiographic index (CRI-index) findings of medication-related osteonecrosis of jaws (MRONJs) and non-medication related osteonecrosis of jaws (n-MRONJs) and predict factors predictive of recurrence and ...
Ilgın Arı +3 more
semanticscholar +1 more source
The Journal of craniofacial surgery (Print)
Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a significant complication associated with bisphosphonates, impacting jaw osteoclasts, and causing altered bone remodelling.
Marwan H Aljohani
semanticscholar +1 more source
Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a significant complication associated with bisphosphonates, impacting jaw osteoclasts, and causing altered bone remodelling.
Marwan H Aljohani
semanticscholar +1 more source
Bisphosphonate-related osteonecrosis of the jaws
Stomatologiya, 2022The number of patients with metabolic osteopathies and oncological diseases occurring with the formation of bone metastases is constantly growing and requires special attention not only of oncologists, but also maxillofacial surgeons, dental surgeons and periodontists, due to severe complications from the oral cavity, against the background of ...
V.V. Sogacheva, V.A. Syomkin
openaire +2 more sources
The Journal of craniofacial surgery (Print), 2020
OBJECTIVES The aim of the present study is to report a case series of patients with peri-implant medication-related osteonecrosis of the jaw (MRONJ), in particular describing the onset of the condition and surgical treatment outcome.
M. Nisi +5 more
semanticscholar +1 more source
OBJECTIVES The aim of the present study is to report a case series of patients with peri-implant medication-related osteonecrosis of the jaw (MRONJ), in particular describing the onset of the condition and surgical treatment outcome.
M. Nisi +5 more
semanticscholar +1 more source
Bisphosphonate-associated osteonecrosis of the jaw
Menopause International, 2007The term 'osteonecrosis of the jaw' is typically used to describe the exposure of bone within the oral cavity. These lesions are often painful and can result in pathological fracture and disfigurement in severe cases. Infection and dental extractions commonly precede presentation, although lesions can occur spontaneously.
Neil, Basu, David M, Reid
openaire +2 more sources
Axitinib-related osteonecrosis of the jaw
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017Tyrosine kinase inhibitors (TKIs) are oral chemotherapy drugs used primarily to treat leukemias, renal cell carcinomas, gastrointestinal stromal tumors, and neuroendocrine tumors. Within this group, a number of drugs have already been implicated in jaw necrosis.
Vinod, Patel +3 more
openaire +2 more sources
Biophosphonate-Related Osteonecrosis of the Jaws
Dental Clinics of North America, 2008In 2003 and 2004, the first reports of patients who developed necrosis of the jawbones while taking biophosphonates appeared in literature; most patients were on this drug for treatment of cancer and some osteoporosis. Since then, more than 500 cases have been identified and the number of these cases continues to grow.
Salvatore L, Ruggiero, Sook-Bin, Woo
openaire +2 more sources
Bisphosphonate-Related Osteonecrosis of the Jaw
Annals of Plastic Surgery, 2020Objectives Antiresorptive agents for bone pain were widely used to treat patients with advanced osteoporosis, multiple myeloma, and bone metastatic cancer. In recent years, however, bisphosphonate-related osteonecrosis of the jaw (BRONJ) has been a rare but major complication of this therapy.
Hsin-I, Chien +6 more
openaire +2 more sources
The Journal of craniofacial surgery (Print), 2019
Medication-related osteonecrosis of the jaw are bone exposures in the maxillofacial region that does not heal after 8 weeks from the observation of a health care provider in patients with history of the intake of antiresorptive agents and no previous ...
N. Valente +4 more
semanticscholar +1 more source
Medication-related osteonecrosis of the jaw are bone exposures in the maxillofacial region that does not heal after 8 weeks from the observation of a health care provider in patients with history of the intake of antiresorptive agents and no previous ...
N. Valente +4 more
semanticscholar +1 more source